Target-mediated pharmacokinetic/pharmacodynamic model based meta-analysis and dosing regimen optimization of a long-acting release formulation of exenatide in patients with type 2 diabetes mellitus
Lancet 353, 593594 10.1016/S0140-6736(05)75654-3 [DOI] [PubMed] [Google Scholar] Segura M., Farr M., Pichini S., Peir A
Here's what manufacturers, payers, and pharmacies need to know
,
There is as well a great opportunity for combining both metabolomic and genomic data for an integrated and comprehensive approach to both diagnosis and ongoing management
113,114,115 Importantly, even in cases of isolated peripancreatic necrosis, where the pancreatic parenchyma appears normal on imaging, the rate of complications and need for intervention remain significantly higher than those in interstitial edematous pancreatitis